The tumor specific unique redox status makes the rapidly proliferating cells more dependent on redox protective mechanisms such as MTH1 upregulation, opening a novel therapeutic window for the selective induction of cancer cell apoptosis via oxidative stress overload, sparing the normal cells. Here, NUDT1 is linked to cancer.